ASCO2024 special: Circulating kidney injury m...

In this episode, UROONCO PCa associate editor Prof. Claudia Kesch interviews Dr. Neeraj Agarwal, from Dana-Farber Cancer Institute on the recent results of the TALAPRO-3 trial. This trial investigates the efficacy and safety of TALA + ENZA in men with mCSPC bearing HRR gene alter ...  Show more

How can small renal masses be managed beyond surgery, and how should the most appropriate approach be selected for each patient?In this episode, Prof. Daniela Oprea-Lager (NL) is joined by Assoc. Prof. Lorenzo Bianchi (IT) and Dr. Giuseppe Basile (GB) to discuss the evolving mana ...  Show more

<span class= "normaltextrun"><span style= "font-size: 11.0pt; line-height: 107%; font-family: 'Calibri',sans-serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-theme-font: major-fareast; mso-ansi-language: EN-US; mso-f ...

Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ...  Show more

In this episode, we review the high-yield topic of Renal Cell Carcinoma from the Oncology section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets 

This episode covers renal cell carcinoma.

Written notes can be found at https://zerotofinals.com/surgery/urology/renalcellcarcinoma/ or in the urology section of the Zero to Finals surgery book ...